Brief: Seres Therapeutics Q2 EPS USD -0.22
13/08/2024 12:00
Aug 13 (Reuters) - Seres Therapeutics Q2 net income USD -32.87 million. * Q2 operating income USD -31.345 million * Q2 operating expenses USD 31.345 million
Recent news on Seres Therapeutics
See all newsChinese automakers make tech-led pitch for Europe's premium car market
Brief: Seres Therapeutics - May Offer Up To $300 Million Of Securities
Seres Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Seres Therapeutics Q2 net income turns positive on VOWST sale gain
Brief: Seres Therapeutics Q2 EPS USD 0.47